Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Scholar Rock Holding Corporation Common Stock (SRRK)

Biological Products, (no Disgnostic Substances)

https://www.scholarrock.com

Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The company's lead product candidate is Apitegroma which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Its other product comprises SRK-181, an inhibitor of the activation of latent transforming growth factor beta-1 ("TGFβ1"), for the treatment of cancers that are resistant to anti-PD-(L)1 antibody therapies.

301 BINNEY STREET, 3RD FLOOR
CAMBRIDGE, MA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/24/2018

Market Cap

742,702,528

Shares Outstanding

72,140,000

Weighted SO

72,143,258

Total Employees

N/A

Upcoming Earnings

08/14/2024

Similar Tickers

TCRR --.--%

RVMD --.--%

BDTX --.--%

BCEL --.--%

PASG --.--%

GLUE --.--%

DSGN --.--%

HOWL --.--%

IKNA --.--%

Beta

0.8550

Last Div

0.0000

Range

5.93-21.17

Chg

-0.1000

Avg Vol

934393

Mkt Cap

742702528

Exch

NASDAQ

Country

US

Phone

857 259 3860

DCF Diff

8.6396

DCF

0.4804

Div Yield

0.0000

P/S

63.6966

EV Multiple

-3.4632

P/FV

6.7237

Div Yield %

0.0000

P/E

-4.4074

PEG

-0.4427

Payout

0.0000

Current Ratio

6.0368

Quick Ratio

6.0368

Cash Ratio

2.8306

DSO

40.3190

DIO

0.0000

Op Cycle

40.3190

DPO

488.6813

CCC

-448.3623

Gross Margin

0.7877

Op Margin

-17.9778

Pretax Margin

-17.4825

Net Margin

-17.4825

Eff Tax Rate

-0.0095

ROA

-0.8985

ROE

-1.1496

ROCE

-1.0812

NI/EBT

1.0000

EBT/EBIT

0.9725

EBIT/Rev

-17.9778

Debt Ratio

0.2480

D/E

0.4211

LT Debt/Cap

0.2662

Total Debt/Cap

0.2963

Int Coverage

0.0000

CF/Debt

-2.9963

Equity Multi

1.6978

Rec Turnover

9.0528

Pay Turnover

0.7469

Inv Turnover

0.0000

FA Turnover

0.5417

Asset Turnover

0.0514

OCF/Share

-1.7415

FCF/Share

-1.7420

Cash/Share

1.9676

OCF/Sales

-14.4599

FCF/OCF

1.0003

CF Coverage

-2.9963

ST Coverage

-21.6546

CapEx Coverage

-3746.7333

Div&CapEx Cov

-3746.7333

P/BV

6.7237

P/B

6.7237

P/S

63.6966

P/E

-4.4074

P/FCF

-4.4039

P/OCF

-5.3286

P/CF

-5.3286

PEG

-0.4427

P/S

63.6966

EV Multiple

-3.4632

P/FV

6.7237

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation